Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Health Related Quality of Life and Multidimensional Evaluations of a Cohort of Prostate Cancer Subjects Aged ≥ 60 Years Initiating Gonadotropin-Releasing Hormone (GNRH) Agonist Therapy

NCT03516110 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT03516110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03516110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Health Related Quality of Life and Multidimensional Evaluations of a Cohort of Prostate Cancer Subjects Aged ≥ 60 Years Initiating Gonadotropin-Releasing Hormone (GNRH) Agonist Therapy
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
March 9, 2018
Completion date
February 28, 2020
Enrollment
831 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer